Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications Health Condition 2: E112- Type 2 diabetes mellitus with kidney complications Health Condition 3: E114- Type 2 diabetes mellitus with neurological complications Health Condition 4: E113- Type 2 diabetes mellitus with ophthalmic complications Health Condition 5: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: T2DM patients of age between 18 to 60 years T2DM patients of both genders T2DM patients on pharmacotherapy for at least 1 year Willing to give consent to participate in the study Able to furnish at least one previous investigation reports
Exclusion criteria
Exclusion criteria: Type 1 DM patients. Newly diagnosed T2DM Gestational diabetes mellitus Juvenile diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in hba1c from baselineTimepoint: reduction in hba1c from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| time taken for treatment intensification despite of high glycemic indexTimepoint: more than 3 months | — |
Countries
India
Contacts
Vydehi institute of medical sciences and research Centre